Annual Working Capital
$255.49 M
-$21.23 M-7.67%
31 December 2023
Summary:
Terns Pharmaceuticals annual working capital is currently $255.49 million, with the most recent change of -$21.23 million (-7.67%) on 31 December 2023. During the last 3 years, it has risen by +$187.44 million (+275.45%). TERN annual working capital is now -7.67% below its all-time high of $276.72 million, reached on 31 December 2022.TERN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$365.09 M
+$145.81 M+66.49%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly working capital is currently $365.09 million, with the most recent change of +$145.81 million (+66.49%) on 30 September 2024. Over the past year, it has increased by +$106.73 million (+41.31%). TERN quarterly working capital is now at all-time high.TERN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.7% | +41.3% |
| 3 y3 years | +275.4% | +112.4% |
| 5 y5 years | +196.7% | - |
TERN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.7% | +275.4% | at high | +167.4% |
| 5 y | 5 years | -7.7% | +1379.0% | at high | +2997.1% |
| alltime | all time | -7.7% | +1379.0% | at high | +2997.1% |
Terns Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $365.09 M(+66.5%) |
| June 2024 | - | $219.28 M(-7.5%) |
| Mar 2024 | - | $237.07 M(-7.2%) |
| Dec 2023 | $255.49 M(-7.7%) | $255.49 M(-1.1%) |
| Sept 2023 | - | $258.37 M(-5.7%) |
| June 2023 | - | $274.08 M(-4.7%) |
| Mar 2023 | - | $287.56 M(+3.9%) |
| Dec 2022 | $276.72 M | $276.72 M(+51.2%) |
| Sept 2022 | - | $183.06 M(+34.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $136.56 M(-7.7%) |
| Mar 2022 | - | $147.95 M(-7.6%) |
| Dec 2021 | $160.11 M(+135.3%) | $160.11 M(-6.9%) |
| Sept 2021 | - | $171.90 M(-5.1%) |
| June 2021 | - | $181.05 M(-4.5%) |
| Mar 2021 | - | $189.66 M(+178.7%) |
| Dec 2020 | $68.05 M(+293.9%) | $68.05 M(-640.0%) |
| Sept 2020 | - | -$12.60 M(-173.0%) |
| Dec 2019 | $17.27 M(-79.9%) | $17.27 M |
| Dec 2018 | $86.10 M | - |
FAQ
- What is Terns Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual working capital year-on-year change?
- What is Terns Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly working capital year-on-year change?
What is Terns Pharmaceuticals annual working capital?
The current annual working capital of TERN is $255.49 M
What is the all time high annual working capital for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual working capital is $276.72 M
What is Terns Pharmaceuticals annual working capital year-on-year change?
Over the past year, TERN annual working capital has changed by -$21.23 M (-7.67%)
What is Terns Pharmaceuticals quarterly working capital?
The current quarterly working capital of TERN is $365.09 M
What is the all time high quarterly working capital for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly working capital is $365.09 M
What is Terns Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, TERN quarterly working capital has changed by +$106.73 M (+41.31%)